title: Drugs and diabetes: understanding the new breed of cardiovascular safety trials.
authors.affiliation: Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK. Electronic address: amanda.adler@addenbrookes.nhs.uk.
authors.forename: Amanda Ingham
authors.initials: AI
authors.lastname: Adler
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy*; D017277:Drug Approval / Q000379:methods*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology* / Q000592:standards*; D011358:Product Surveillance, Postmarketing / Q000379:methods / Q000592:standards; D018570:Risk Assessment / Q000331:legislation & jurisprudence / Q000592:standards*
chemical_list: D007004:Hypoglycemic Agents